Raloxifene Improves Bone Mechanical Properties in Mice Previously Treated with Zoledronate
Sign Up to like & getrecommendations! Published in 2017 at "Calcified Tissue International"
DOI: 10.1007/s00223-017-0257-4
Abstract: Bisphosphonates represent the gold-standard pharmaceutical agent for reducing fracture risk. Long-term treatment with bisphosphonates can result in tissue brittleness which in rare clinical cases manifests as atypical femoral fracture. Although this has led to an… read more here.
Keywords: significantly higher; zoledronate; treated zoledronate; treatment ... See more keywords